This work is licensed under a
Creative Commons Attribution 4.0 International License
[1] L. Brunton et al., The Pharmacological Basis of Therapeutics, 10th ed, McGraw-Hill, (2001).
[2] K. Parfitt, W. Martindale, The Complete Drug Reference, The Pharmaceutical Press, London. 720 (1999) 836.
[3] D.W. Cushman et al., Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids, Biochemistry. 16 (1977) 5484-5491.
[4] P.R.S. Ribeiro, L. Pezza, H.R. Pezza, A simple spectrophotometric method for the determination of captopril in pharmaceutical preparations using ammonium molybdate, Eclet. Quim. 35 (2010) 79-88.
[5] P.D. Tzanavaras et al., Reversed flow-injection manifold for the spectrophotometric determination of captopril based on its inhibitory effect on the Co(II) – 2, 2'-dipyridyl-2-pyridylhydrazone complex formation, Talanta. 57 (2002) 575-581.
[6] A.M. El-Didamony, E.A.H. Erfan, Spectrochim, Utilization of oxidation reactions for the spectrophotometric determination of captopril using brominating agents, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 75(3) (2010).
[7] N.E. Enany, F. Bela, M. Rizk, Novel Spectrophotometric method for the assay of captopril in dosage forms using 2, 6-Dichloroquinone-4-Chlorimide, Int. J. Biomed Sci. 4 (2008) 146-154.
[8] M. Skowron, W. Ciesielski, Spectrophotometric determination of methimazole, D-penicillamine, captopril, and disulfiram in pure form and drug formulations, J. Anal. Chem. 66 (2011) 714.
[9] I. Panderi, M. Parissi-Poulou, Determination of captopril and captopril-hydrochlorothiazide combination in tablets by derivative UV spectrophotometry, Int. J. Pharm. 86(2-3) (1992) 99-106.
[10] J.A.V. Prior, J.L.M. Santos, J.L.F.C. Lima, Exploiting kinetic spectrophotometric determination of captopril, an angiotensin-converting enzyme inhibitor, in a multi-pumping flow system, Anal. Chim. Acta. 600 (2007) 183-187.
[11] Y. El-Shabrawy, N. El-Enany, K. Salem, Sensitive kinetic spectrophotometric determination of captopril and ethamsylate in pharmaceutical preparations and biological fluids, Il Farmaco. 59(10) (2004) 803-808.
[12] Z. Moldovan, A Spectrophotometric method for captopril determination by using fluorescein natrium-bromine system, Rev. Roum. Chim. 57 (2012) 721-727.
[13] N. Rahman et al., A sensitive kinetic spectrophotometric method for the determination of captopril in bulk and dosage forms, Acta. Pharm. 56 (2006) 347–357.
[14] M. Jain, S.N. Shrivastava, A stability indicating assay method for captopril tablets by high performance liquid chromatography for stability studies, Anal Chem. 3 (2006) 78-83.
[15] D. Meiju, Determination of captopril in human plasma by liquid chromatography/tandem mass spectrometry, Anal Lett. 40 (2007) 3245-3255.
[16] R.J. Kok et al., Bioanalysis of captopril: two sensitive high-performance liquid chromatographic methods with pre-or postcolumn fluorescent labeling, J. Chrom. B. Biomed. Sci. Appl. 693(1) (1997) 181-189.
[17] J.A. Squella et al., Voltammetric behaviour of captopril in pharmaceutical forms, Bol. Soc. Chil. Quim. 37 (1992) 259.
[18] P. Passamont, V. Bartcci, F. Pucciarelli, Determination of Captropril using adsorptive cathodic differential pulse stripping voltammetry with the HMDE, Journal of electroanalytical chemistry and interfacial electrochemistry. 230(1) (1987) 99-108.
[19] G.K. Ziyatdinova, G.K. Budnikov, V.I. Pogorel'tsev, Determination of captopril in pharmaceutical forms by stripping voltammetry, J. Anal. Chem. 61 (2006) 798-800.
[20] S.M. Al-Ghannam, A.M. El-Brashy, B.S. Al-Farhan, Fluorimetric determination of some thiol compounds in their dosage forms, Il Farmaco. 57 (2002) 625-629.
[21] M.A. El Reis, F.M. Abou Attia, I.M.M. Kenawy, Indirect determination of captopril by AAS, J. Pharm. Biomed. Anal. 23 (2000) 249–254.
[22] A.M. Pimenta, A.N. Araújo, M.C.B.S.M. Montenegro, Sequential injection analysis of captopril based on colorimetric and potentiometric detection, Anal. Chim. Acta. 438 (2001) 31-38.
[23] Jr. E. Schmidt, W.R. Melchert, F.R.P. Rocha, Flow-injection iodimetric determination of captopril in pharmaceutical preparations, J. Braz. Chem. Soc. 20 (2009) 236-242.
[24] B. Li, Z. Zhang, M. Wu, Flow-injection chemiluminescence determination of captopril using on-line electrogenerated silver (II) as the oxidant, Microchemical Journal. 70(2) (2001) 85-91.
[25] P.D. Tzanavaras, Automated Determination of Captopril by Flow and Sequential Injection Analysis: A Review, Anal. Lett. 44 (2011) 560-576.
[26] M. A. Khalilzadeh et al., Determination of captopril in patient human urine using ferrocenemonocarboxylic acid modified carbon nanotubes paste electrode, Chin. Chem. Lett. 21 (2010) 1467-1470.
[27] S.R. Crouch et al., Kinetic determinations and some kinetic aspects of analytical chemistry, Anal. Chem. 70 (1998) 53–106.
[28] A. Espinosa-Mansilla et al., Kinetic determination of ansamicins in pharmaceutical formulations, Anal. Chim. Acta. 376 (1998) 365-375.
[29] R.A. Bartsch, S. Hunig, H. Quast, Mechanism of oxidation of 3-methyl-2-benzothiazolinone hydrazone by potassium ferricyanide in aqueous methanol, J. Am. Chem. Soc. 92 (1970) 6007–6011.
[30] A.R. Kartritzky, C.W. Rees, Comprehensive Heterocyclic Chemistry, Pergamon Press, Oxford. 7 (1984) 527.
[31] M. Kopanica et al., Kinetic Methods in Chemical Analysis, Eds., Elsevier, Amsterdam, The Netherlands, (1983).
[32] D.P. Bendito, M. Silva, Kinetic Methods in Analytical Chemistry, chapter 11, John Wiley & Sons, New York, USA, (1988).
[33] J. Rose, Advanced Physico-chemical Experiments: A Textbook of Pract. Phys. Chemistry and Calculations, Pittman, London, (1964).
[34] USP – The United States Pharmacopeia: The National Formulary. 25th ed. Rockville: The United States Pharmacopeial Convention – Twinbrook Parkway, (2007).